Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 968 results for "hepatitis"

Sovriad deaths spur drug label rewrite

Three people have died after taking Sovriad to treat hepatitis C, and drugmaker Janssen Pharmaceutical K.K. has been ordered to revise the medicine's packaging to state that usage should be halted if indicated by blood tests, the health ministry ... Japan Times, 21 hours ago

180 images for hepatitis

Newstalk, 2 days ago
Evening Herald, 1 day ago
Newstalk, 1 day ago
The Guardian Express, 3 days ago
Irish Times, 2 days ago
EverydayHealth.com, 3 days ago
One News Page United Kingdom, 3 days ago
Pharma Letter, 2 days ago
MedIndia, 1 week ago
Deccan Chronicle, 1 week ago
Irish Examiner

Hepatitis C group paid €13,000 for weekend of pampering

POSITIVE Action - the support group for women infected with Hepatitis C - racked up a bill of nearly €13,000 over one weekend hotel break, documents show. The support group, which was criticised in a HSE audit for its extravagant use of public ...
 Irish Independent1 day ago Positive Action has questions to answer, but the greatest tragedy is its closure  Irish Independent2 days ago New hepatitis group unlikely to receive HSE funding  Irish Examiner2 days ago HSE cuts funding to Hepatitis C support group which ran up expenses of €250,000  Irish Independent3 days ago
[x]  

Hepatitis B Reagents

ViroStat has expanded its offering of hepatitis B reagents including its MONOTOPE and OMNITOPE antibodies and Recombinant Antigens. Specificities include surface antigen (HBsAg), HB core, HB e, pre-S1, pre-S2 and HB-X. Applications for these ...
 Bioscience Technology Online1 day ago

New Hepatitis C drug could be available shortly

An early access programme to a new drug for up to 200 people with Hepatitis C could be operational within a few weeks,but subject to an agreement with the drug makers on price, according toMinister for Health, Leo Varadkar. Sovaldi has been shown ...
 RTE Online1 day ago

37 miss UPDF entry over Hepatitis B infection

At least 37 applicants that turned up for recruitment into the army have been turned away for testing positive with Hepatitis B. The group that had passed all the other subjected tests had their progress cut short on Thursday evening by the ...
 Uganda Daily Monitor1 day ago
Irish Times

Positive Action former directors defend spending

Former directors of the hepatitis C support group Positive Action have defended the group's spending and criticised the portrayal of them as ladies who lunch. Some €2.3 million was allocated between 2009 and 2013 to Positive Action, which was set ...
 Irish Times2 days ago Garda inquiry into Positive Action group almost complete  Irish Times2 days ago Alcohol, kennels, manicures - Hep C group spending revealed  Irish Times2 days ago Concerns raised about lavish spending at State-funded group over a year ago  Breaking News.ie2 days ago
[x]  

Promising hepatitis C drug = 100% gain

Shares of Regulus Therapeutics (RGLS) jumped more than 100% in one day after preliminary testing of a hepatitis C drug looked positive. La Jolla, Calif.-based Regulus shares gained $6.98, or 103%, to $13.75 after the company told investors that ...
 USA Today3 days ago Regulus surges on early hepatitis C drug data  Investor's Business Daily3 days ago Regulus Therapeutics more than doubles on early data for microRNA treatment for hepatitis C  FOXBusiness.com3 days ago Here's Why Regulus Skyrocketed  Bidness Etc3 days ago
[x]  
California Healthline

Giving pricey hepatitis drug to prisoners may be financially wise

(Reuters Health) - When prisoners have hepatitis C, treating them with expensive new antiviral drugs makes fiscal sense despite the hefty price tag, according to a new study. Based on computer models, new pricey drug combinations that treat ...
 Reuters4 days ago Pricey Hepatitis Drug a Good Bet in U.S. Prisons, Study Says  US News & World Report5 days ago Officials Say Hepatitis C Drug Too Pricey To Give to All Calif. Inmates  California Healthline4 days ago Gilead Sciences, Inc.'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons  BioSpace4 days ago
[x]  

Student Dies of Suspected Hepatitis-E

GULBARGA : The Central University of Karnataka, situated in Gulbarga district, is in the news again for the wrong reasons. A student died due to suspected Hepatitis-E in Hyderabad on Wednesday, a university source said. Shivaganga Rumma, ...
 New Indian Express2 days ago Central Varsity Shut After Student's Death  New Indian Express1 day ago Varsity shut for 10 days over mysterious virus  Bangalore Mirror1 day ago

Regulus Therapeutics: Gilead's New Competitor?

Regulus Therapeutics released positive results for its hepatitis C drug candidate yesterday; Bidness Etc explores if the company can be a threat for Gilead Page 1 of 2 Click Ticker to See live coverage Regulus Therapeutics Inc ( RGLS ) ...
 Bidness Etc2 days ago This Stock Goes On Massive Tear Amid Positive Hepatitis C Study  Benzinga.com3 days ago Regulus Therapeutics demonstrates human proof-of-concept  Crawford Financial Planning3 days ago Therapix Names Jan Turek CEO  FierceBiotech1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less